Plerixafor-moblized stem cells alone are capable of inducing early engraftment across the MHC-haploidentical canine barrier.
Thakar
Monica S
MS
Santos
Erlinda B
EB
Fricker
Simon
S
Bridger
Gary
G
Storb
Rainer
R
Sandmaier
Brenda M
BM
D000818:Animals; D019380:Anti-HIV Agents / Q000494:pharmacology; D001596:Benzylamines; D000080027:Cyclams; D004285:Dogs; D006239:Haplotypes; D019650:Hematopoietic Stem Cell Mobilization / Q000379:methods*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006571:Heterocyclic Compounds / Q000494:pharmacology*; D015395:Histocompatibility Antigens Class I / Q000235:genetics* / Q000276:immunology
D019380:Anti-HIV Agents; D001596:Benzylamines; D000080027:Cyclams; D006571:Heterocyclic Compounds; D015395:Histocompatibility Antigens Class I; C039692:histocompatibility antigen DLA; C088327:plerixafor